Atogepant (Qulipta) is an oral calcitonin gene-related peptide (CGRP) antagonist used as a second-line preventive therapy manage one type of chronic headache. For which type of headache is it primarily indicated?
A. Chronic migraine B. Sinus headache C. Cluster headache D. Tension-type headache